$5.20
0.19[3.79%]
Last update: 9:22AM Get Real Time Here
Aurinia Pharmaceuticals: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Mar 07, 2024 | Peter Greenleaf | CHIEF EXECUTIVE OFFICER | -126.981K | $5.60 | -$711.09K | SELL | -7.70% | 1.522114M | Mar 06 | View |
Mar 07, 2024 | Joseph M Miller | CHIEF FINANCIAL OFFICER | -34.811K | $5.60 | -$194.94K | SELL | -6.56% | 495.928K | Mar 06 | View |
Mar 07, 2024 | Matthew Maxwell Donley | EVP, OPS & STRATEGY | -40.665K | $5.51 | -$224.06K | SELL | -6.51% | 584.072K | Mar 06 | View |
Mar 07, 2024 | Scott Habig | CHIEF COMMERCIAL OFFICER | -17.777K | $5.60 | -$99.55K | SELL | -3.61% | 474.587K | Mar 06 | View |
Mar 07, 2024 | Stephen P Robertson | EVP, GENERAL COUNSEL | -57.745K | $5.60 | -$323.37K | SELL | -11.51% | 443.824K | Mar 06 | View |
Feb 29, 2024 | Volker Knappertz | EVP, RESEARCH AND DEVELOPMENT | -4.93K | $6.10 | -$30.07K | SELL | -1.52% | 319.128K | Feb 27 | View |
Feb 22, 2024 | Volker Knappertz | EVP, RESEARCH AND DEVELOPMENT | -25.146K | $5.48 | -$137.80K | SELL | -7.20% | 324.058K | Feb 20 | View |
Feb 22, 2024 | Scott Habig | CHIEF COMMERCIAL OFFICER | 179.645K | $5.48 | -$86.95K | GRANT | 57.45% | 492.364K | Feb 20 | View |
May 23, 2023 | David R.W. Jayne M.D. | DIRECTOR | 9.31K | $11.26 | -$98.33K | SELL-OPTIONS | 23.28% | 49.31K | May 18 - May 23 | View |
May 23, 2023 | Joseph P Hagan | DIRECTOR | 8.461K | $10.58 | -$2.88K | SELL-OPTIONS | 241.74% | 11.961K | May 18 - May 19 | View |
May 23, 2023 | Daniel Billen | DIRECTOR | 13.393K | $11.26 | -$52.36K | SELL-OPTIONS | 66.97% | 33.393K | May 18 - May 23 | View |
May 23, 2023 | Hector MacKayDunn | DIRECTOR | 13.225K | $11.26 | -$54.25K | SELL-OPTIONS | 120.23% | 24.225K | May 18 - May 23 | View |
May 23, 2023 | Jill Leversage | DIRECTOR | 13.228K | $11.26 | -$54.22K | SELL-OPTIONS | 249.58% | 18.528K | May 18 - May 23 | View |
Mar 06, 2023 | George M. Milne Jr., Ph.D. | DIRECTOR | 20K | $8.91 | $178.28K | BUY | 40.00% | 70K | Mar 02 | View |
Mar 06, 2023 | Joseph M Miller | CHIEF FINANCIAL OFFICER | 218.125K | $8.94 | -$100.99K | GRANT | 192.88% | 331.214K | Mar 02 | View |
Mar 06, 2023 | Stephen P Robertson | EVP, GENERAL COUNSEL | 185.408K | $8.94 | -$173.45K | GRANT | 157.18% | 303.364K | Mar 02 | View |
Mar 06, 2023 | Peter Greenleaf | CHIEF EXECUTIVE OFFICER | 634.657K | $8.94 | -$292.79K | GRANT | 182.21% | 982.968K | Mar 02 | View |
Nov 23, 2022 | Matthew Maxwell Donley | EX VP, INTERNAL OPERATIONS | 10K | $4.66 | $46.60K | BUY | 55.78% | 27.927K | Nov 21 | View |
Nov 14, 2022 | Scott Habig | CHIEF COMMERCIAL OFFICER | 5K | $5.01 | $25.07K | BUY | ∞ | 5K | Nov 09 | View |
Browse insider trades on all stocks.